illustration of the heart and cardiovascular system)

Rhophylac®

Have a Question? Use Our New Chat Feature! Chat with our Medical Information Specialists by clicking on the Chat with us now available in the lower right corner of this screen.

Product Information Key Publications

Key Publications

ITP

Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac®) in chronic immune thrombocytopenic purapura
Aledort LM et al
Hematology 2007
Request | Ask a Question

Suppression of Rh Isoimmunization

Pharmacokinetics of anti-D IgG in pregnant RhD-negative women

Bichler, J et al
J Obstet Gynaecol 2003
Request | Ask a Question

Suppression of Rh Isoimmunization

Efficacy and safety of a new, chromatographically purified rhesus (D) immunoglobulin

MacKenzie, IZ et al
European Journal of Obstetrics & Gynecology and Reproductive Biology 2004
Request | Ask a Question
For U.S. Healthcare Professionals only
For U.S. Healthcare Professionals only

The purpose of this CSL Behring Medical Affairs website is to support Healthcare Professionals with scientific information. This website is also a channel for U.S. Healthcare Professionals to submit questions or connect with CSL Behring U.S. Healthcare Professionals. The information provided is for educational purposes only and is not intended to promote any products. By continuing to use this site you are acknowledging that you are a US Healthcare Professional

I am a U.S. Healthcare Professional
I am not a healthcare professional
toggle chat overlay
toggle chat overlay